Pathological Conditions, Anatomical: Clinical Trials

4303 completed, 1622 unknown, 899 recruiting, 467 not yet recruiting. 4258 Not applicable, 621 Phase 2, 481 Phase 3, 461 Phase 4, 272 Phase 1.

By phase and status

Phase	Trials	Status
Not applicable	4258	Completed 2146, Unknown 852, Recruiting 485, Not yet recruiting 265, Terminated 179, Active not recruiting 164, Withdrawn 103, Enrolling by invitation 48, Suspended 16
Phase 2	621	Completed 344, Unknown 80, Recruiting 64, Terminated 54, Not yet recruiting 30, Withdrawn 27, Active not recruiting 19, Enrolling by invitation 2, Suspended 1
Phase 3	481	Completed 269, Unknown 82, Recruiting 38, Terminated 35, Withdrawn 19, Active not recruiting 18, Not yet recruiting 17, Enrolling by invitation 2, Suspended 1
Phase 4	461	Completed 252, Unknown 92, Terminated 37, Recruiting 25, Not yet recruiting 21, Withdrawn 17, Active not recruiting 15, Enrolling by invitation 1, Suspended 1
Phase 1	272	Completed 142, Unknown 44, Recruiting 25, Terminated 24, Withdrawn 17, Not yet recruiting 13, Active not recruiting 4, Enrolling by invitation 2, Suspended 1
Early Phase 1	68	Completed 28, Not yet recruiting 9, Unknown 9, Recruiting 6, Terminated 5, Withdrawn 5, Active not recruiting 3, Enrolling by invitation 3

Follow Pathological Conditions, Anatomical: new trials by email Literature Review of Pathological Conditions, Anatomical trials Research Report on Pathological Conditions, Anatomical

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults Multi-nutrient supplement, Exercise - Sarcopenia	Not applicable	Withdrawn	McMaster University		2030-01-20	2024-01-30
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease FGF-1, Placebo - Peripheral Arterial Disease, Stenosis	Phase 1 / Phase 2	Not yet recruiting	Venturis Therapeutics, Inc.	24	2028-10-15	2026-08-19
The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp Shared Decision Making using a Patient Decision Aid. - Shared Decision Making, Colonic Polyp	Phase 2	Not yet recruiting	Vejle Hospital	110	2028-02-01	2026-04-30
AV-1959R Vaccine in Individuals With Preclinical Alzheimer's Disease AV-1959R, Placebo - Preclinical Alzheimer's Disease, Alzheimer Disease	Phase 2	Not yet recruiting	Institute for Molecular Medicine	160	2027-10-01	2026-10-21
Does MI Have a Therapeutic Role in Arthroscopic Rotator Cuff Repair? Motor Imagery, Physical Therapy - Rotator Cuff Tears, Motor Imagery	Not applicable	Suspended	Alanya Alaaddin Keykubat University	36	2027-09-15	2026-10-28
SUTURE TYPE AND RECURRENCE RISK AFTER INCISIONAL HERNIA REPAIR Suturing of hernia defect with non-absorbable suture, Suturing of hernia defect with slowly absorbable suture - Ventral Incisional Hernia	Not applicable	Not yet recruiting	Ersta Diakoni	980	2027-09-01	2026-10-23
Heterozygous Individuals for AGXT and Kidney Stones Controlled Diet - Kidney Stone, Urolithiasis, Calcium Oxalate	Not applicable	Enrolling by invitation	University of Alabama at Birmingham	4	2027-07-01	2026-08-31
The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery PT Group, Usual Care - Ventral Hernia, Ventral Incisional Hernia	Not applicable	Not yet recruiting	Thomas Jefferson University	60	2027-07-01	2026-10-22
Sarcopenia in Chronic Kidney Disease (CKD) Patients Valine, EEA - Chronic Kidney Disease, Sarcopenia	Early Phase 1	Not yet recruiting	The University of Texas Health Science Center at San Antonio	20	2027-07-01	2026-11-02
The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck Nutrition counseling, Fresubin Supportan - Head &Amp;Amp; Neck Squamous Cell Carcinoma	Phase 1 / Phase 2	Not yet recruiting	Anna Arthur, PhD	15	2027-06-01	2026-08-07
PATH-03 Paraguay Feasibility Study ePATH System will be used to create an endoAVF - Kidney Disease, End-Stage	Not applicable	Not yet recruiting	Pathfinder Medical	20	2027-03-01	2026-09-17
Recover@Home Postoperative Follow-up Study Recovery@home - Hernia, Inguinal, Hernia, Femoral	Not applicable	Not yet recruiting	Icahn School of Medicine at Mount Sinai	194	2027-03-01	2026-07-20
Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia EN001, EN001 Placebo - Sarcopenia	Phase 1 / Phase 2	Not yet recruiting	ENCell	132	2027-03-01	2026-09-11
Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES) - Critical Illness, Sarcopenia	Early Phase 1	Not yet recruiting	University of Maryland, Baltimore	78	2027-03-01	2026-05-06
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH). TRA16, Placebo - Enteric Hyperoxaluria	Phase 2	Not yet recruiting	Wuhan Kangfude Urolithiasis Research Institute Co., Ltd.	30	2027-03-01	2026-10-13
A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease GAL-101 Salt, Placebo - Mild to Moderate Alzheimer's Disease	Phase 2	Not yet recruiting	Galimedix Therapeutics Inc	100	2027-02-28	2026-08-27
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. Minoxidil oral solution, Placebo oral solution - Androgenetic Alopecia, Androgenetic Alopecia (AGA)	Phase 3	Not yet recruiting	Eurofarma Laboratorios S.A.	372	2027-01-31	2026-04-14
A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma Evolocumab, Routine Lipid Management, Autoinjector - Coronary Artery Disease, Hypercholesterolemia	Phase 4	Not yet recruiting	Amgen	308	2027-01-31	2026-09-21
Randomized Evaluation of Lumbar Injection Effectiveness and Function Triojection® System, Selective Nerve Root Block (SNRB) - Lumbar Radiculopathy, Lumbar Disc Herniation	Not applicable	Not yet recruiting	SpinaFX Medical Inc.	300	2027-01-15	2026-10-07
Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss DA-005, Topical minoxidil 5%, DA-002 - Androgenetic Alopecia, Female Pattern Baldness	Phase 3	Withdrawn	Applied Biology, Inc.		2027-01-15	2026-11-02

Showing 20 of 8357. Sign in to see all of them.

Narrower conditions

Sarcopenia (1301)  ·  Pelvic Organ Prolapse (513)  ·  Kidney Calculi (506)  ·  Hernia, Inguinal (489)  ·  Alopecia (473)  ·  Intervertebral Disc Displacement (438)  ·  Muscular Atrophy (405)  ·  Colonic Polyps (375)  ·  Plaque, Amyloid (272)  ·  Hernia (256)  ·  Constriction, Pathologic (229)  ·  Arteriovenous Fistula (223)  ·  Hernia, Ventral (212)  ·  Motor Activity (203)  ·  Gallstones (189)

Broader conditions

Pathological Conditions, Signs and Symptoms (8355)  ·  Signs and Symptoms (2494)  ·  Neurologic Manifestations (2235)  ·  Nervous System Diseases (2114)  ·  Neuromuscular Manifestations (1652)  ·  Atrophy (1626)  ·  Hernia (1503)  ·  Pathologic Processes (1475)  ·  Digestive System Diseases (1268)  ·  Urogenital Diseases (1260)  ·  Muscular Atrophy (1241)  ·  Female Urogenital Diseases and Pregnancy Complications (1223)  ·  Female Urogenital Diseases (1204)  ·  Male Urogenital Diseases (1087)

Interventions

Exercise (113)  ·  Resistance Training (101)  ·  Bupivacaine (58)  ·  Minoxidil (51)  ·  Sodium Chloride (51)  ·  Colonoscopy (47)  ·  Saline Solution (42)  ·  Blood Specimen Collection (40)  ·  Standard of Care (37)  ·  Surveys and Questionnaires (35)  ·  Control Groups (34)  ·  Acetaminophen (25)  ·  Dietary Supplements (25)  ·  Herniorrhaphy (25)  ·  Lidocaine (24)

Sponsors

Assiut University (107)  ·  National Taiwan University Hospital (65)  ·  Mayo Clinic (57)  ·  Mansoura University (55)  ·  The Cleveland Clinic (52)  ·  Cairo University (49)  ·  Assistance Publique - Hôpitaux de Paris (41)  ·  Novartis Pharmaceuticals (39)  ·  Ain Shams University (35)  ·  Maastricht University Medical Center (33)  ·  Karolinska Institutet (32)  ·  Northwestern University (32)  ·  Seoul National University Hospital (32)  ·  Wake Forest University Health Sciences (32)  ·  Zagazig University (30)

Countries

United States (2190)  ·  China (578)  ·  Turkey (Türkiye) (561)  ·  France (461)  ·  Canada (361)  ·  Italy (359)  ·  Egypt (356)  ·  United Kingdom (351)  ·  Spain (329)  ·  Germany (298)  ·  Taiwan (228)  ·  Belgium (215)  ·  Denmark (207)  ·  Netherlands (196)  ·  South Korea (180)

Top investigators

Saleh K Saleh, MD (9)  ·  Frederik Berrevoet, MD (8)  ·  Ben Chew, MD (7)  ·  Hany F Badawy, MD (7)  ·  Lan Zhu (7)  ·  Lan Zhu, MD (7)  ·  Luc JC van Loon, PhD (7)  ·  Stuart M Phillips, PhD (7)  ·  Frederik Helgstrand, MD (6)  ·  Guohua Zeng, PH.D and M.D (6)  ·  James E Lingeman, MD (6)

Results publications

PMID 30312372, PMID 20392703, PMID 33710614, PMID 32069356, PMID 19941278, PMID 24737557, PMID 32033882, PMID 37431855, PMID 28095426, PMID 33773598, PMID 34184246, PMID 35305260, PMID 36184076, PMID 11074683, PMID 15933795, PMID 16003309, PMID 21855968, PMID 22048651, PMID 22498635, PMID 23549122, PMID 26337427, PMID 26573101, PMID 26634203, PMID 27238616, PMID 28040257, PMID 28641875, PMID 28754926, PMID 31081853, PMID 32769645, PMID 32941253, PMID 33207004, PMID 33548517, PMID 36787836, PMID 37341961, PMID 37951571, PMID 37955353, PMID 38197558, PMID 38263353, PMID 38477494, PMID 38789313, PMID 39324520, PMID 39532605, PMID 39584361, PMID 41743463, PMID 41917311, PMID 42481842, PMID 42573020, PMID 12028177, PMID 12472328, PMID 12756590

NIH funding

2017 (16), 2023 (14), 2016 (13), 2015 (11), 2019 (10), 2025 (10), 2018 (9), U10HD041261 (6), U10HD041267 (6), 2009 (5), 2014 (5), P30AG028740 (5), U10HD041250 (5), 2008 (4), P01DK043881 (4)